Literature DB >> 26348872

Non-canonical actions of Nogo-A and its receptors.

Stefanie Seiler1, Stefano Di Santo2, Hans Rudolf Widmer3.   

Abstract

Nogo-A is a myelin associated protein and one of the most potent neurite growth inhibitors in the central nervous system. Interference with Nogo-A signaling has thus been investigated as therapeutic target to promote functional recovery in CNS injuries. Still, the finding that Nogo-A presents a fairly ubiquitous expression in many types of neurons in different brain regions, in the eye and even in the inner ear suggests for further functions besides the neurite growth repression. Indeed, a growing number of studies identified a variety of functions including regulation of neuronal stem cells, modulation of microglial activity, inhibition of angiogenesis and interference with memory formation. Aim of the present commentary is to draw attention on these less well-known and sometimes controversial roles of Nogo-A. Furthermore, we are addressing the role of Nogo-A in neuropathological conditions such as ischemic stroke, schizophrenia and neurodegenerative diseases.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell signaling; Distribution; Neurodegenerative diseases; Nogo-A; Nogo-receptor; Regenerative medicine

Mesh:

Substances:

Year:  2015        PMID: 26348872     DOI: 10.1016/j.bcp.2015.08.113

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Agenesis of the corpus callosum in Nogo receptor deficient mice.

Authors:  Seung-Wan Yoo; Mary G Motari; Ronald L Schnaar
Journal:  J Comp Neurol       Date:  2016-07-08       Impact factor: 3.215

2.  NogoA Neutralization Promotes Axonal Restoration After White Matter Injury In Subcortical Stroke.

Authors:  Laura Otero-Ortega; Mari Carmen Gómez-de Frutos; Fernando Laso-García; Alba Sánchez-Gonzalo; Arturo Martínez-Arroyo; Exuperio Díez-Tejedor; María Gutiérrez-Fernández
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

3.  A Nogo-Like Signaling Perspective from Birth to Adulthood and in Old Age: Brain Expression Patterns of Ligands, Receptors and Modulators.

Authors:  Gabriella Smedfors; Lars Olson; Tobias E Karlsson
Journal:  Front Mol Neurosci       Date:  2018-02-19       Impact factor: 5.639

4.  Nogo-A regulates myogenesis via interacting with Filamin-C.

Authors:  SunYoung Park; Ji-Hwan Park; Un-Beom Kang; Seong-Kyoon Choi; Ahmed Elfadl; H M Arif Ullah; Myung-Jin Chung; Ji-Yoon Son; Hyun Ho Yun; Jae-Min Park; Jae-Hyuk Yim; Seung-Jun Jung; Sang-Hyup Kim; Young-Chul Choi; Dae-Seong Kim; Jin-Hong Shin; Jin-Sung Park; Keun Hur; Sang-Han Lee; Eun-Joo Lee; Daehee Hwang; Kyu-Shik Jeong
Journal:  Cell Death Discov       Date:  2021-01-06

5.  The isoform A of reticulon-4 (Nogo-A) in cerebrospinal fluid of primary brain tumor patients: influencing factors.

Authors:  Olga Martyna Koper; Joanna Kamińska; Anna Milewska; Karol Sawicki; Zenon Mariak; Halina Kemona; Joanna Matowicka-Karna
Journal:  Oncotarget       Date:  2018-05-18

6.  Circular RNA Encoded Amyloid Beta peptides-A Novel Putative Player in Alzheimer's Disease.

Authors:  Dingding Mo; Xinping Li; Carsten A Raabe; Timofey S Rozhdestvensky; Boris V Skryabin; Juergen Brosius
Journal:  Cells       Date:  2020-09-29       Impact factor: 6.600

7.  Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.

Authors:  Gian-Carlo Eyer; Stefano Di Santo; Ekkehard Hewer; Lukas Andereggen; Stefanie Seiler; Hans Rudolf Widmer
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.